Article Text

Download PDFPDF
▼Asenapine for bipolar I disorder?
  • Relevant BNF section: BNF 4.2.3


About 1 in 100 people has bipolar disorder (manic depression) at some point in their lives.1 Associated mood swings of depression and mania can be both unpleasant and destructive.2 It is advised to start medical treatment early, and traditionally this has involved the use of mood stabilisers, antipsychotics and antidepressants.2 ▼Asenapine (Sycrest – Lundbeck) is a new sublingual antipsychotic drug, licensed for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults.3 Here we review the evidence and practical implications associated with the use of this new medication.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Relevant BNF section: BNF 4.2.3

View Full Text